Pharmaxis Ltd (AU:SNT) has released an update.
Clinical stage drug developer Syntara Limited announces its participation in the ShareCafe Small Cap ‘Hidden Gems’ Webinar, where CEO Gary Phillips will discuss the company’s focus on novel treatments for blood cancers and fibrotic diseases. The company, which is advancing multiple clinical studies including a promising candidate for myelofibrosis, invites interested parties to attend the event virtually on May 17, 2024. Syntara, which also earns royalties from two respiratory products, is actively involved in research collaborations and has several drug candidates targeting various inflammatory and fibrotic diseases.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
